Chiu‐Ching Huang
China Medical University(TW)China Medical University Hospital(TW)
Publications by Year
Research Areas
Dialysis and Renal Disease Management, Central Venous Catheters and Hemodialysis, Renal Diseases and Glomerulopathies, Diverse Scientific and Economic Studies, Complement system in diseases
Most-Cited Works
- → The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment(2020)208 cited
- Metformin-associated lactic acidosis: case reports and literature review.(2003)
- → Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications(2014)69 cited
- → Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults(2021)64 cited
- → IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy(2016)52 cited
- → Long‐term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients(2014)42 cited
- → Bacteremia in Hemodialysis and Peritoneal Dialysis Patients